Skip to content

Clinical trials

Observational Disease Progression trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Progression Phase: Observational Clear all

220 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20042
20051
20072
20084
20095
20104
20118
20129
20138
20147
201516
201610
201710
20187
201916
202021
20219
202214
202310
202414
202514
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed92
Unknown status43
Recruiting35
Active, not recruiting21
Not yet recruiting20
Withdrawn6
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)7
University of Zurich5
Massachusetts General Hospital4
Peking Union Medical College Hospital4
Radboud University Medical Center4
Ain Shams University3
Assiut University3
Monteris Medical3
National Cancer Institute (NCI)3
Peking University People's Hospital3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease Progression220
Parkinson Disease12
Recurrence12
Urinary Bladder Neoplasms10
HIV Infections9
Multiple Sclerosis9
Amyotrophic Lateral Sclerosis8
Non-Muscle Invasive Bladder Neoplasms8
Pulmonary Disease, Chronic Obstructive8
Breast Neoplasms7

Trials

Showing 26 to 50 of 220. Each trial links to its page on Pharma Observatory.

120 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.